Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > California’s ZEV Mandate Faces Uphill Battle

<< Previous

Bullboard Posts

Next >>

Post by TechOneon Dec 23, 2020 10:47pm

142 Views

Post# 32175613

California’s ZEV Mandate Faces Uphill Battle

By 2035, all new cars and passenger trucks sold in California will be required to be zero-emissions compliant.

This will present challenges for manufacturers, particularly around an increasing need for rare-earth minerals and metals such as #Tungsten - critical in #electricvehicles.

In the following article by Madeleine Winer, Lewis Black, CEO of Almonty Industries Inc discusses material supply challenges, and the growing need for #Tungsten in the US manufacturing industry - https://bit.ly/3oAiwhY

https://www.aftermarketnews.com/californias-zev-mandate-faces-uphill-battle/

<< Previous

Bullboard Posts

Next >>

5 steps to mastering risk management in the stock market